195 related articles for article (PubMed ID: 24338950)
1. Honokiol inhibits androgen receptor activity in prostate cancer cells.
Hahm ER; Karlsson AI; Bonner MY; Arbiser JL; Singh SV
Prostate; 2014 Apr; 74(4):408-20. PubMed ID: 24338950
[TBL] [Abstract][Full Text] [Related]
2. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells.
Hahm ER; Sakao K; Singh SV
Prostate; 2014 Sep; 74(12):1209-21. PubMed ID: 25043291
[TBL] [Abstract][Full Text] [Related]
3. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
Hahm ER; Singh KB; Singh SV
Cell Cycle; 2016 Sep; 15(17):2309-20. PubMed ID: 27341160
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression and inhibition of nuclear translocation of androgen receptor by diallyl trisulfide in human prostate cancer cells.
Stan SD; Singh SV
Clin Cancer Res; 2009 Aug; 15(15):4895-903. PubMed ID: 19622577
[TBL] [Abstract][Full Text] [Related]
5. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction.
Hahm ER; Arlotti JA; Marynowski SW; Singh SV
Clin Cancer Res; 2008 Feb; 14(4):1248-57. PubMed ID: 18281560
[TBL] [Abstract][Full Text] [Related]
6. Anti‑proliferative effect of honokiol on SW620 cells through upregulating BMP7 expression via the TGF‑β1/p53 signaling pathway.
Li Q; Ma Y; Liu XL; Mu L; He BC; Wu K; Sun WJ
Oncol Rep; 2020 Nov; 44(5):2093-2107. PubMed ID: 32901874
[TBL] [Abstract][Full Text] [Related]
7. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
[TBL] [Abstract][Full Text] [Related]
8. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
Wang Y; Liu G; Tong D; Parmar H; Hasenmayer D; Yuan W; Zhang D; Jiang J
Prostate; 2015 Aug; 75(11):1187-96. PubMed ID: 25894097
[TBL] [Abstract][Full Text] [Related]
9. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
Kim SH; Singh SV
Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
[TBL] [Abstract][Full Text] [Related]
10. Capillarisin blocks prostate-specific antigen expression on activation of androgen receptor in prostate carcinoma cells.
Tsui KH; Chang YL; Feng TH; Hou CP; Lin YH; Yang PS; Lee BW; Juang HH
Prostate; 2018 Mar; 78(4):242-249. PubMed ID: 29164633
[TBL] [Abstract][Full Text] [Related]
11. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
[TBL] [Abstract][Full Text] [Related]
12. Honokiol inhibits hepatoma carcinoma cell migration through downregulated Cyclophilin B expression.
Lee YS; Jeong S; Kim KY; Yoon JS; Kim S; Yoon KS; Ha J; Kang I; Choe W
Biochem Biophys Res Commun; 2021 May; 552():44-51. PubMed ID: 33743348
[TBL] [Abstract][Full Text] [Related]
13. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
14. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
17. Honokiol affects melanoma cell growth by targeting the AMP-activated protein kinase signaling pathway.
Kaushik G; Kwatra D; Subramaniam D; Jensen RA; Anant S; Mammen JM
Am J Surg; 2014 Dec; 208(6):995-1002; discussion 1001-2. PubMed ID: 25450590
[TBL] [Abstract][Full Text] [Related]
18. Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells.
Chen XR; Lu R; Dan HX; Liao G; Zhou M; Li XY; Ji N
Int J Oral Sci; 2011 Jan; 3(1):34-42. PubMed ID: 21449214
[TBL] [Abstract][Full Text] [Related]
19. [Both CK2 catalytic subunits involves in androgen receptor signaling in prostate cancer cells].
Yao K; Gao XY; Huang BJ; Li ZS; Zhou FJ; Li BY; Han H
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3360-3. PubMed ID: 24418032
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-185 downregulates androgen receptor expression in the LNCaP prostate carcinoma cell line.
Liu C; Chen Z; Hu X; Wang L; Li C; Xue J; Zhang P; Chen W; Jiang A
Mol Med Rep; 2015 Jun; 11(6):4625-32. PubMed ID: 25673182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
